We are live on ! Find out more
NMC

NEA Management Company Portfolio holdings

AUM $1.59B
1-Year Est. Return 234.06%
This Fund
S&P 500
This Quarter Est. Return
+3.54%
1 Year Est. Return
+234.06%
3 Year Est. Return
+822.97%
5 Year Est. Return
+865.41%
10 Year Est. Return
+12,585.11%
AUM
$2.36B
AUM Growth
-$126M
Cap. Flow
+$59.8M
Cap. Flow %
2.53%
Top 10 Hldgs %
55.13%
Holding
55
New
9
Increased
3
Reduced
6
Closed
1

Top Buys

Rank Stock Value
1
NKTX icon
Nkarta
NKTX
+$85.6M
2
INZY
Inozyme Pharma
INZY
+$60.7M
3
ANNX icon
Annexon
ANNX
+$58.6M
4
MTCR
Metacrine, Inc. Common Stock
MTCR
+$31.4M
5
VRNA
Verona Pharma
VRNA
+$26.9M

Top Sells

Rank Stock Value
1
SPT icon
Sprout Social
SPT
+$109M
2
NET icon
Cloudflare
NET
+$49.6M
3
CRSP icon
CRISPR Therapeutics
CRSP
+$44.4M
4
MRSN
Mersana Therapeutics
MRSN
+$40.4M
5
RIGL icon
Rigel Pharmaceuticals
RIGL
+$5.93M

Sector Composition

Rank Sector Weight
1 Healthcare 87%
2 Technology 10.03%
3 Consumer Discretionary 1.95%
4 Industrials 1.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AKTX
51
Akari Therapeutics
AKTX
$21.4M
$787K 0.03%
565
– –
PLTR icon
52
Palantir
PLTR
$412B
$712K 0.03%
+74,974
New +$712K
ALTR
53
DELISTED
Altair Engineering Inc
ALTR
$503K 0.02%
+11,977
New +$482K
VIRX
54
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$162K 0.01%
37,093
-1
-0% -$9
RIGL icon
55
Rigel Pharmaceuticals
RIGL
$825M
– –
-324,315
Closed -$5.93M
1 2
3

Similar funds

ADL
Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return
CCP
Cryder Capital Partners London, United Kingdom $1.59B AUM 0.23% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SW
SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
W
Wealthquest Cincinnati, Ohio $1.59B AUM 18.1% 1-Year Est. Return
PIS
PPSC Investment Service Tokyo, Japan $1.58B AUM 47.89% 1-Year Est. Return
FWP
Falcon Wealth Planning Ontario, California $1.58B AUM 20.99% 1-Year Est. Return

NEA Management Company's Q3 2020 Portfolio in Review

As of Q3 2020, NEA Management Company held 55 positions worth $2.36B, down 5.1% from $2.49B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

NEA Management Company's Q3 2020 filing shows 9 new, 3 increased, 6 reduced and 1 closed positions. Its largest new stake was Nkarta: 2,904,974 shares worth $87.3M. The largest sale was Sprout Social, an estimated $109M.

By sector, the portfolio is most concentrated in Healthcare at 87% of assets, up from 81% a quarter earlier, followed by Technology and Consumer Discretionary.

  • NEA Management Company's largest Q3 2020 buy was Nkarta: 2,904,974 shares worth $87.3M.
  • NEA Management Company added most to Verona Pharma in Q3 2020, an estimated $26.9M increase.
  • NEA Management Company's biggest Q3 2020 reduction was Sprout Social, cutting an estimated $109M.
  • NEA Management Company fully exited Rigel Pharmaceuticals in Q3 2020, selling an estimated $5.93M.
  • NEA Management Company's ten largest holdings make up 55% of its $2.36B portfolio in Q3 2020.
  • NEA Management Company opened 9 new positions and closed 1 in Q3 2020.
  • NEA Management Company's portfolio value fell 5.1% quarter-over-quarter to $2.36B.

Based on NEA Management Company's 13F filing for Q3 2020, filed 6 Nov 2020.